Dexamethasone cipecilate dry powderAlternative Names: Erizas; NS-126; NS-126C
Latest Information Update: 04 Feb 2016
At a glance
- Originator Hisamitsu Pharmaceutical
- Developer Nippon Shinyaku; Yooyoung Pharmaceutical
- Class Antiallergics; Antiasthmatics; Glucocorticoids; Pregnadienetriols
- Mechanism of Action Glucocorticoid receptor agonists; Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Allergic rhinitis
- Discontinued Asthma